JMN Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
JMN Financial's VRTX Position: Q2 2026 in Review
JMN Financial increased its Vertex Pharmaceuticals (VRTX) stake by 24% in Q2 2026, buying an estimated $59.4K and bringing the position to 688 shares worth $342K. The position accounts for 0.27% of the portfolio, ranked #115.
JMN Financial first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,663 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- JMN Financial held 688 shares of Vertex Pharmaceuticals worth $342K as of Q2 2026.
- JMN Financial bought 134 Vertex Pharmaceuticals shares in Q2 2026, an estimated $59.4K.
- Vertex Pharmaceuticals made up 0.27% of JMN Financial's portfolio in Q2 2026, its #115 holding.
- JMN Financial first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,663 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on JMN Financial's 13F filing for Q2 2026, filed 10 Aug 2026.